Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Vaccination in elite athletes.
[typhoid]
Public
health
vaccination
guidelines
can
not
be
easily
transferred
to
elite
athletes
.
An
enhanced
benefit
from
preventing
even
mild
diseases
is
obvious
but
stronger
interference
from
otherwise
minor
side
effects
has
to
be
considered
as
well
.
Thus
,
special
vaccination
guidelines
for
adult
elite
athletes
are
required
.
In
most
of
them
,
protection
should
be
strived
for
against
tetanus
,
diphtheria
,
pertussis
,
influenza
,
hepatitis
A
,
hepatitis
B
,
measles
,
mumps
and
varicella
.
When
living
or
traveling
to
endemic
areas
,
the
athletes
should
be
immune
against
tick-borne
encephalitis
,
yellow
fever
,
Japanese
encephalitis
,
poliomyelitis
,
typhoid
fever
,
and
meningococcal
disease
.
Vaccination
against
pneumococci
and
Haemophilus
influenzae
type
b
is
only
relevant
in
athletes
with
certain
underlying
disorders
.
Rubella
and
papillomavirus
vaccination
might
be
considered
after
an
individual
risk-benefit
analysis
.
Other
vaccinations
such
as
cholera
,
rabies
,
herpes
zoster
,
and
Bacille
Calmette-
Guérin
(
BCG
)
can
not
be
universally
recommended
for
athletes
at
present
.
Only
for
a
very
few
diseases
,
a
determination
of
antibody
titers
is
reasonable
to
avoid
unnecessary
vaccinations
or
to
control
efficacy
of
an
individual
's
vaccination
(
especially
for
measles
,
mumps
,
rubella
,
varicella
,
hepatitis
B
and
,
partly
,
hepatitis
A
)
.
Vaccinations
should
be
scheduled
in
a
way
that
possible
side
effects
are
least
likely
to
occur
in
periods
of
competition
.
Typically
,
vaccinations
are
well
tolerated
by
elite
athletes
,
and
resulting
antibody
titers
are
not
different
from
the
general
population
.
Side
effects
might
be
reduced
by
an
optimal
selection
of
vaccines
and
an
appropriate
technique
of
administration
.
Very
few
discipline-
specific
considerations
apply
to
an
athlete
's
vaccination
schedule
mainly
from
the
competition
and
training
pattern
as
well
as
from
the
typical
geographical
distribution
of
competitive
sites
.
Diseases
Validation
Diseases presenting
"fever"
symptom
22q11.2 deletion syndrome
acute rheumatic fever
alexander disease
allergic bronchopulmonary aspergillosis
canavan disease
carcinoma of the gallbladder
child syndrome
congenital toxoplasmosis
cushing syndrome
cystinuria
dracunculiasis
erdheim-chester disease
esophageal adenocarcinoma
esophageal carcinoma
familial mediterranean fever
focal myositis
hodgkin lymphoma, classical
lamellar ichthyosis
legionellosis
locked-in syndrome
malignant atrophic papulosis
neonatal adrenoleukodystrophy
neuralgic amyotrophy
oculocutaneous albinism
papillon-lefèvre syndrome
pyomyositis
pyruvate dehydrogenase deficiency
scrub typhus
severe combined immunodeficiency
sneddon syndrome
systemic capillary leak syndrome
triple a syndrome
typhoid
waldenström macroglobulinemia
wolf-hirschhorn syndrome
This symptom has already been validated